The increasing use of silver nanoparticles (AgNPs) in consumer products raises the risk of human toxicity. Currently, there are no therapeutic options or established treatment protocols in cases of AgNPs intoxication. We demonstrated previously that thiol antioxidants compounds can reverse the cytotoxicity induced by AgNPs in Huh-7 hepatocarcinoma cells. Here, we investigated the use of N-acetylcysteine (NAC) against the systemic toxic effects of AgNPs (79.3 nm) in rats. Biochemical, histopathological, hematological, and oxidative parameters showed that a single intravenous injection of AgNPs (5 mg/kg b.w.) induced deleterious effects such as hepatotoxicity, potentially as a result of AgNPs accumulation in the liver. Treatment with a single...
Background Silver nanoparticles have antibacterial properties and their use is growing in ...
Silver (Ag) nanoparticles (AgNPs) are among the most commercially utilized nanoparticles worldwide. ...
Oral subchronic exposure to silver nanoparticles in ratsDOI: 10.1016/j.fct.2016.04.010Because of the...
With the increasing use and incorporation of nanoparticles (NPs) into consumer products, screening f...
Objective(s): Nanotechnology and nanoparticles are increasingly recognized for their potential appli...
Objective(s): Nanotechnology and nanoparticles are increasingly recognized for their potential appli...
With the increasing use and incorporation of nanoparticles (NPs) into consumer products, screening f...
Abstract Silver nanoparticles (AgNPs) have been generally used due to their strong antibacterial, an...
The potential risk of a nanoparticle as a medical application has raised wide concerns, and this stu...
AbstractSilver nanoparticles are being used increasingly for biomedical purposes because of their br...
As a widely applied nanomaterial, silver nanomaterials (AgNMs) have increased public concern about t...
<div><div><p>Nanotechnology is a most promising field for generating new applications in medicine, a...
<p>We report the results of a 28-day oral exposure study in rats, exposed to <20 nm noncoat...
Background. Silver nanoparticles have found wider and increasing biomedical applications due to thei...
Because of its antibacterial activity nanosilver is one of the most commonly used nanomaterials. It ...
Background Silver nanoparticles have antibacterial properties and their use is growing in ...
Silver (Ag) nanoparticles (AgNPs) are among the most commercially utilized nanoparticles worldwide. ...
Oral subchronic exposure to silver nanoparticles in ratsDOI: 10.1016/j.fct.2016.04.010Because of the...
With the increasing use and incorporation of nanoparticles (NPs) into consumer products, screening f...
Objective(s): Nanotechnology and nanoparticles are increasingly recognized for their potential appli...
Objective(s): Nanotechnology and nanoparticles are increasingly recognized for their potential appli...
With the increasing use and incorporation of nanoparticles (NPs) into consumer products, screening f...
Abstract Silver nanoparticles (AgNPs) have been generally used due to their strong antibacterial, an...
The potential risk of a nanoparticle as a medical application has raised wide concerns, and this stu...
AbstractSilver nanoparticles are being used increasingly for biomedical purposes because of their br...
As a widely applied nanomaterial, silver nanomaterials (AgNMs) have increased public concern about t...
<div><div><p>Nanotechnology is a most promising field for generating new applications in medicine, a...
<p>We report the results of a 28-day oral exposure study in rats, exposed to <20 nm noncoat...
Background. Silver nanoparticles have found wider and increasing biomedical applications due to thei...
Because of its antibacterial activity nanosilver is one of the most commonly used nanomaterials. It ...
Background Silver nanoparticles have antibacterial properties and their use is growing in ...
Silver (Ag) nanoparticles (AgNPs) are among the most commercially utilized nanoparticles worldwide. ...
Oral subchronic exposure to silver nanoparticles in ratsDOI: 10.1016/j.fct.2016.04.010Because of the...